Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nyse  >  Pfizer Inc       

SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

Pfizer Inc. : Pfizer Will Remove Claims on Breast and Colon Health From Centrum Label -Reuters

share with twitter share with LinkedIn share with facebook
share via e-mail
0
07/05/2012 | 11:26pm CEST

Pfizer Inc. (>> Pfizer Inc.) said it will remove claims that its Centrum multivitamin supplements promote breast and colon health from labels over the next six months, following a complaint by a watchdog group, Reuters reported Thursday.

The company will also revise websites and advertising for Centrum, the report said.

The report said the Center for Science in the Public Interest sent a letter to Pfizer Chief Executive Ian Read in April outlining its complaints and threatening a lawsuit if the claims weren't removed.

In a statement, Pfizer said it "disagrees with CSPI's concerns, but has agreed to make these changes in order to fully resolve the issues raised by the organization," Reuters reported.

Full story at http://www.reuters.com/article/2012/07/05/pfizer-centrum-idUSL2E8I5BR820120705

Write to nymonitoring@dowjones.com

Stocks mentioned in the article : Pfizer Inc.
share with twitter share with LinkedIn share with facebook
share via e-mail
0
React to this article
Latest news on PFIZER INC
08:56p GLAXOSMITHKLINE : What we must do to avert antibiotic catastrophe
07:05p PFIZER : UN High Commissioner for Human Rights Zeid Ra'ad Al Hussein greets Pfiz..
11:33a PFIZER : Champix label updated to include new safety and efficacy data
08:49aDJTax Rule Scuppers $8 Billion Deal -- WSJ
05/23DJCF, OCI Ditch Merger, Citing New U.S. Tax Rules--2nd Update
05/23DJSamsung Targets U.S. Drug Market With Remicade Knockoff
05/23 PFIZER : EU lifts suicide warning on Pfizer's smoking-cessation pill
05/23 Allergan CEO says company is 'weeks away' from closing Teva deal
05/23 ACQUISITION OF ANACOR PHARMACEUTICAL : ANAC) Under Investigation for Investors
05/23 TUNISIA : Abraaj unimed ipo
Advertisement
News chart
Full-screen chart
Income Statement Evolution
More Financials